These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25909201)

  • 1. Natriuretic peptides, obesity and cardiovascular diseases.
    Castro-Torres Y; Katholi RE
    Rev Assoc Med Bras (1992); 2015; 61(1):19-20. PubMed ID: 25909201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
    Rubattu S; Sciarretta S; Valenti V; Stanzione R; Volpe M
    Am J Hypertens; 2008 Jul; 21(7):733-41. PubMed ID: 18464748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and metabolic effects of natriuretic peptides.
    Moro C; Berlan M
    Fundam Clin Pharmacol; 2006 Feb; 20(1):41-9. PubMed ID: 16448393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides and fat metabolism.
    Moro C
    Curr Opin Clin Nutr Metab Care; 2013 Nov; 16(6):645-9. PubMed ID: 23945222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renin-angiotensin-aldosterone system and natriuretic peptide system--reference to cardiovascular diseases].
    Yasue H; Mizuno Y; Harada E; Ito T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():164-9. PubMed ID: 15506362
    [No Abstract]   [Full Text] [Related]  

  • 6. Natriuretic peptides: update on Peptide release, bioactivity, and clinical use.
    Richards AM
    Hypertension; 2007 Jul; 50(1):25-30. PubMed ID: 17452510
    [No Abstract]   [Full Text] [Related]  

  • 7. Natriuretic peptides in cardiometabolic regulation and disease.
    Zois NE; Bartels ED; Hunter I; Kousholt BS; Olsen LH; Goetze JP
    Nat Rev Cardiol; 2014 Jul; 11(7):403-12. PubMed ID: 24820868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic Peptides and Cardiometabolic Health.
    Gupta DK; Wang TJ
    Circ J; 2015; 79(8):1647-55. PubMed ID: 26103984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic directions for the natriuretic peptides in cardiovascular diseases: what's on the horizon.
    Burnett JC
    J Cardiol; 2006 Nov; 48(5):235-41. PubMed ID: 17136818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome.
    Schlueter N; de Sterke A; Willmes DM; Spranger J; Jordan J; Birkenfeld AL
    Pharmacol Ther; 2014 Oct; 144(1):12-27. PubMed ID: 24780848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides: linking heart and adipose tissue in obesity and related conditions--a systematic review.
    Beleigoli AM; Diniz MF; Ribeiro AL
    Obes Rev; 2009 Nov; 10(6):617-26. PubMed ID: 19563456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides.
    Seven E
    Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Consequences of Acute Kidney Injury.
    Legrand M; Rossignol P
    N Engl J Med; 2020 Jun; 382(23):2238-2247. PubMed ID: 32492305
    [No Abstract]   [Full Text] [Related]  

  • 14. Impairment of the natriuretic peptide system in follitropin receptor knockout mice and reversal by estradiol: implications for obesity-associated hypertension in menopause.
    Belo NO; Sairam MR; Dos Reis AM
    Endocrinology; 2008 Mar; 149(3):1399-406. PubMed ID: 18063689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
    Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
    N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications.
    Savoia C; Volpe M; Alonzo A; Rossi C; Rubattu S
    Clin Sci (Lond); 2009 Nov; 118(4):231-40. PubMed ID: 19886866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Natriuretic peptides and their use in clinical practice according to the guidelines of the European Society of Cardiology].
    Stryjewski PJ; Nessler B; Paweł M; Badacz L; Nowak J; Nessler J
    Przegl Lek; 2014; 71(1):33-5. PubMed ID: 24712266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in congenital heart disease: do natriuretic peptides hold the key?
    Alonso-Gonzalez R; Dimopoulos K
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):773-84. PubMed ID: 23750686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corin: a new player in the regulation of salt-water balance and blood pressure.
    Armaly Z; Assady S; Abassi Z
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):713-22. PubMed ID: 24100222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):663-84, ix. PubMed ID: 18775358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.